PatientsVille.com LogoPatientsVille.com

Intracerebral Hemorrhage | Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage

Intracerebral Hemorrhage research study

What is the primary objective of this study?

This is a randomized, double-blind, placebo-controlled, multicenter clinical trial that will be carried out in Mexico. The purpose of this study is to test whether a 3-month treatment with fluoxetine enhances motor recovery in non-depressed patients with acute intracerebral hemorrhage.

Who is eligible to participate?

Inclusion Criteria: - Patients who had an acute intracerebral hemorrhage within the past 10 days causing hemiparesis or hemiplegia - Fugl-Meyer motor scale (FMMS) scores of 55 or less - Written informed consent for participation in the trial Exclusion Criteria: - Severe post-stroke disability (National Institutes of Health stroke scale [NIHSS] score >20) - Premorbid disability, evidenced by residual motor deficit from a previous stroke - Comprehension deficit or severe aphasia - Previous diagnosis of depression or one of the following: - Hospital Anxiety and Depression Scale score ≥11 points - Taking antidepressant drugs two weeks before inclusion - Taking neuroleptic drugs or benzodiazepines two weeks before inclusion - Other major diseases with life expectancy less than 3 months.

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Intracerebral Hemorrhage

Motor Impairment

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:Fluoxetine

Drug:Placebo

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Fluoxetinefluoxetine per os 20 mg daily

Placeboper os daily

Study Status

Terminated

Start Date: November 2012

Completed Date: August 2014

Phase: Phase 3

Type: Interventional

Design:

Primary Outcome: Fugl Meyer Motor Scale score

Secondary Outcome: Barthel Index

Study sponsors, principal investigator, and references

Principal Investigator: Juan M Marquez-Romero, MD

Lead Sponsor: Universidad Autónoma de Aguascalientes

Collaborator:

More information:https://clinicaltrials.gov/show/NCT01737541

Marquez-Romero JM, Arauz A, Ruiz-Sandoval JL, Cruz-Estrada Ede L, Huerta-Franco MR, Aguayo-Leytte G, Ruiz-Franco A, Silos H. Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials. 2013 Mar 19;14:77. doi: 10.1186/1745-6215-14-77.

Discuss Prozac